Offenbach, Germany

Dietmar Gunesch

This inventor holds 1 USPTO granted patent. Top assignee: Degussa Aktiengesellschaft. Active years: 1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dietmar Gunesch. Retrieved from https://idiyas.com/inventor/dietmar-gunesch

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 1987

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dietmar Gunesch: Innovator in Pharmaceutical Synergy

Introduction

Dietmar Gunesch is a notable inventor based in Offenbach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent that explores the synergistic effects of drug combinations.

Latest Patents

Gunesch holds a patent for the "Combination of flupirtin and anticholinergic acting spasmolytic." This invention highlights the enhanced efficacy observed when Flupirtin is combined with an anticholinergic spasmolytic, showcasing his expertise in pharmacology and drug interactions. He has 1 patent to his name.

Career Highlights

Throughout his career, Gunesch has been associated with Degussa Aktiengesellschaft, a prominent company in the chemical and pharmaceutical industry. His work has contributed to advancements in pain management and therapeutic applications.

Collaborations

Gunesch has collaborated with esteemed colleagues such as Hans-Peter Breuel and Carl H. Weischer. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Dietmar Gunesch's contributions to pharmaceutical innovation, particularly through his patent on drug combinations, underscore his role as a key figure in the industry. His work continues to influence the development of effective therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…